Featured Research

from universities, journals, and other organizations

Designer Chemical Offers Alzheimer's Hope

Date:
August 3, 2001
Source:
University Of Illinois At Chicago
Summary:
Researchers at the University of Illinois at Chicago have designed and synthesized highly potent inhibitor compounds that could lead to an effective treatment for Alzheimer’s disease. The work was reported in the American Chemical Society’s Journal of Medicinal Chemistry.

Researchers at the University of Illinois at Chicago have designed and synthesized highly potent inhibitor compounds that could lead to an effective treatment for Alzheimer’s disease. The work was reported in the American Chemical Society’s Journal of Medicinal Chemistry.

Arun Ghosh, professor of chemistry, led the UIC research team in collaboration with Jordan Tang, head of the Protein Studies department at the Oklahoma Medical Research Foundation in Oklahoma City.

In earlier work, Ghosh and Tang designed an inhibitor that blocks the action of one of two protein-cutting enzymes, called proteases, thought to be responsible for Alzheimer’s disease. This enzyme, called memapsin 2, severs a longer protein in the brain called amyloid precursor protein, or APP, to produce beta-amyloid, which accumulates in the brain and forms plaques that lead to the development of Alzheimer’s disease.

“This enzyme is probably the most exciting target for an Alzheimer’s drug,” said Ghosh.

Tang discovered the precise location where memapsin 2 cuts APP. Subsequently, Tang and Ghosh demonstrated that a model inhibitor compound attracts memapsin 2 and keeps it from cutting APP — a promising way to halt accumulation of beta-amyloid in the brain. That inhibitor was reported in the Journal of the American Chemical Society last year and was shown to be effective in test tube experiments.

The research team knew that while useful as a model, the inhibitor would not be effective in drug therapy. “That was a preliminary inhibitor,” said Ghosh. “It’s a big one, containing eight peptides — a size that is inconceivable to be a drug candidate.”

Ghosh and his team set out to reduce the molecule’s size in an effort to increase its potential as a drug candidate.

“Peptide-like compounds never make useful drugs because they’re metabolically unstable, they’re insoluble and, perhaps the biggest problem in Alzheimer’s patients, they’re hard to deliver in the human brain,” Ghosh said. The molecule has to be small enough to cross what’s called the blood-brain barrier. “Peptide-like molecules are not very good at penetrating this barrier. Our ultimate goal is to deliver a totally non-peptide inhibitor,” he said.

The current paper describes a new generation of inhibitors designed and tested in the laboratory. These new inhibitors are still potent yet substantially smaller, comparable in size to HIV protease inhibitor drugs now being prescribed.

“Designing a smaller, more potent inhibitor is an important step in the development of an effective treatment for Alzheimer’s patients,” said Tang.

The research is supported by grants from the National Institutes of Health.

The Alzheimer’s Association reports about 4 million Americans now suffer from the disease. It predicts that number will grow as the population ages, unless a cure or prevention is found. Current treatments provide only symptomatic relief.


Story Source:

The above story is based on materials provided by University Of Illinois At Chicago. Note: Materials may be edited for content and length.


Cite This Page:

University Of Illinois At Chicago. "Designer Chemical Offers Alzheimer's Hope." ScienceDaily. ScienceDaily, 3 August 2001. <www.sciencedaily.com/releases/2001/08/010803083854.htm>.
University Of Illinois At Chicago. (2001, August 3). Designer Chemical Offers Alzheimer's Hope. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2001/08/010803083854.htm
University Of Illinois At Chicago. "Designer Chemical Offers Alzheimer's Hope." ScienceDaily. www.sciencedaily.com/releases/2001/08/010803083854.htm (accessed October 21, 2014).

Share This



More Mind & Brain News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Your Birth Season Might Determine Your Temperament

Your Birth Season Might Determine Your Temperament

Newsy (Oct. 20, 2014) A new study says the season you're born in can determine your temperament — and one season has a surprising outcome. Video provided by Newsy
Powered by NewsLook.com
Court Ruling Means Kids' Online Activity Could Be On Parents

Court Ruling Means Kids' Online Activity Could Be On Parents

Newsy (Oct. 17, 2014) In a ruling attorneys for both sides agreed was a first of its kind, a Georgia appeals court said parents can be held liable for what kids put online. Video provided by Newsy
Powered by NewsLook.com
The Best Foods To Boost Your Mood

The Best Foods To Boost Your Mood

Buzz60 (Oct. 17, 2014) Feeling down? Reach for the refrigerator, not the medicine cabinet! TC Newman (@PurpleTCNewman) shares some of the best foods to boost your mood. Video provided by Buzz60
Powered by NewsLook.com
You Can Get Addicted To Google Glass, Apparently

You Can Get Addicted To Google Glass, Apparently

Newsy (Oct. 15, 2014) Researchers claim they’ve diagnosed the first example of the disorder in a 31-year-old U.S. Navy serviceman. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins